1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Leiomyosarcoma Global Clinical Trials Review, H1, 2014

Leiomyosarcoma Global Clinical Trials Review, H1, 2014

  • February 2014
  • -
  • Global Data
  • -
  • 96 pages

Leiomyosarcoma Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Leiomyosarcoma Global Clinical Trials Review, H1, 2014" provides data on the Leiomyosarcoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Leiomyosarcoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Leiomyosarcoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Leiomyosarcoma Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Leiomyosarcoma 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Leiomyosarcoma to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Leiomyosarcoma to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Leiomyosarcoma 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Leiomyosarcoma Therapeutics Clinical Trials 29
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Sarcoma Alliance for Research through Collaboration 32
Clinical Trial Overview of Sarcoma Alliance for Research through Collaboration 32
Janssen Global Services, LLC 33
Clinical Trial Overview of Janssen Global Services, LLC 33
Eisai Co., Ltd. 34
Clinical Trial Overview of Eisai Co., Ltd. 34
Nippon Kayaku Co., Ltd. 35
Clinical Trial Overview of Nippon Kayaku Co., Ltd. 35
Merck and Co., Inc. 36
Clinical Trial Overview of Merck and Co., Inc. 36
Johnson and Johnson 37
Clinical Trial Overview of Johnson and Johnson 37
Eli Lilly and Company 38
Clinical Trial Overview of Eli Lilly and Company 38
Daiichi Sankyo Company, Limited 39
Clinical Trial Overview of Daiichi Sankyo Company, Limited 39
Cell Therapeutics, Inc. 40
Clinical Trial Overview of Cell Therapeutics, Inc. 40
ArQule, Inc. 41
Clinical Trial Overview of ArQule, Inc. 41
Clinical Trial Overview of Top Institutes / Government 42
National Cancer Institute 42
Clinical Trial Overview of National Cancer Institute 42
Gynecologic Oncology Group 44
Clinical Trial Overview of Gynecologic Oncology Group 44
European Organization for Research and Treatment of Cancer 45
Clinical Trial Overview of European Organization for Research and Treatment of Cancer 45
Memorial Sloan Kettering Cancer Center 46
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 46
The University of Texas M. D. Anderson Cancer Center 47
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 47
Robert H. Lurie Comprehensive Cancer Center of Northwestern University 48
Clinical Trial Overview of Robert H. Lurie Comprehensive Cancer Center of Northwestern University 48
New York University School of Medicine 49
Clinical Trial Overview of New York University School of Medicine 49
UNICANCER Group 50
Clinical Trial Overview of UNICANCER Group 50
Case Comprehensive Cancer Center 51
Clinical Trial Overview of Case Comprehensive Cancer Center 51
Five Key Clinical Profiles 52
Appendix 93
Abbreviations 93
Definitions 93
Research Methodology 94
Secondary Research 94
About GlobalData 95
Contact Us 95
Disclaimer 95
Source 96

List of Tables
Leiomyosarcoma Therapeutics, Global, Clinical Trials by Region, 2014* 7
Leiomyosarcoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Leiomyosarcoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Leiomyosarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Leiomyosarcoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Leiomyosarcoma Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Leiomyosarcoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Leiomyosarcoma Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Leiomyosarcoma to Oncology Clinical Trials, G7 Countries (%), 2014* 15
Leiomyosarcoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Leiomyosarcoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Leiomyosarcoma to Oncology Clinical Trials, E7 Countries (%), 2014* 18
Leiomyosarcoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Leiomyosarcoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Leiomyosarcoma Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Leiomyosarcoma Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Leiomyosarcoma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Leiomyosarcoma Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Leiomyosarcoma Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Leiomyosarcoma Therapeutics, Global, Terminated Clinical Trials, 2014* 25
Leiomyosarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Leiomyosarcoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 27
Leiomyosarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
Leiomyosarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Leiomyosarcoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sarcoma Alliance for Research through Collaboration, 2014* 32
Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen Global Services, LLC, 2014* 33
Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2014* 34
Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Nippon Kayaku Co., Ltd., 2014* 35
Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2014* 36
Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson and Johnson, 2014* 37
Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014* 38
Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2014* 39
Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Cell Therapeutics, Inc., 2014* 40
Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by ArQule, Inc., 2014* 41
Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 42
Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Gynecologic Oncology Group, 2014* 44
Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2014* 45
Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014* 46
Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014* 47
Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Robert H. Lurie Comprehensive Cancer Center of Northwestern University, 2014* 48
Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by New York University School of Medicine, 2014* 49
Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by UNICANCER Group, 2014* 50
Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2014* 51

List of Figures
Leiomyosarcoma Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Leiomyosarcoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Leiomyosarcoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Leiomyosarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Leiomyosarcoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Leiomyosarcoma Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Leiomyosarcoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Leiomyosarcoma Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Leiomyosarcoma to Oncology Clinical Trials, G7 Countries (%), 2014* 15
Leiomyosarcoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Leiomyosarcoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Leiomyosarcoma to Oncology Clinical Trials, E7 Countries (%), 2014* 18
Leiomyosarcoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Leiomyosarcoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Leiomyosarcoma Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Leiomyosarcoma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Leiomyosarcoma Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Leiomyosarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Leiomyosarcoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 27
Leiomyosarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
Leiomyosarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29
Leiomyosarcoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
GlobalData Methodology 94

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025 Summary Cardiovascular diseases (CVD), including ischemic heart disease and stroke, are the leading causes of mortality ...

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Ulcerative Colitis: KOL Insight

Ulcerative Colitis: KOL Insight

  • $ 8085
  • Industry report
  • September 2016
  • by Firstword Pharma

Are UC biosimilars a real or perceived threat to branded drugs? Ulcerative colitis (UC) treatment is on the brink. Patents are ending on various branded drugs and clearing the way for an influx of biosimilars; ...

Hepatitis C: Kol Insight

September 2016 $ 8085

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.